NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · IEX Real-Time Price · USD
2.070
-0.030 (-1.43%)
At close: Jul 19, 2024, 4:30 PM
2.010
-0.060 (-2.90%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $12.89 million as of July 22, 2024. Its market cap has decreased by -0.07% in one year.
Market Cap
12.89M
Enterprise Value
13.54M
1-Year Change
-0.07%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $30.60M to $12.89M, a decrease of -57.88%. That is a compound annual growth rate of -28.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 12.90M | 5.74% |
| Dec 29, 2023 | 12.20M | 74.29% |
| Dec 30, 2022 | 7.00M | -46.97% |
| Dec 31, 2021 | 13.20M | -56.87% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QT Imaging Holdings | 13.29M |
| Avalo Therapeutics | 13.21M |
| NeuroSense Therapeutics | 13.20M |
| Addex Therapeutics | 13.17M |
| GeoVax Labs | 12.98M |
| Guardion Health Sciences | 12.75M |
| Purple Biotech | 12.74M |
| STRATA Skin Sciences | 12.73M |